VANCOUVER, BC, June 4, 2015 (GLOBE NEWSWIRE) -- via PRWEB - According to a recently published report by iData Research (http://www.idataresearch.com), growth of the European total intravenous (IV) set market is solely driven by a slight increase in unit sales as the average selling price (ASP) of all device types has been decreasing due to fierce competition and sluggish economic conditions. This market includes primary (dedicated and non-dedicated) and secondary IV sets as well as IV extension sets.
"The increased occurrence of diseases that demand infusion therapy will lead to an increase in the utilization of installed pumps before promoting an increase in unit sales for capital-intensive devices," explains Dr. Kamran Zamanian, CEO of iData. "However, unit sales for secondary IV sets are growing significantly slower than sales of primary IV sets as a result of safety concerns regarding the occurrence of medication error."
Unit sales of primary IV sets are mainly driven by the increasing age of the European population and corresponding growth of the patient pool. Overall market growth has been influenced by strong unit sales growth and a high ASP of primary IV sets dedicated to electronic ambulatory pumps. The growth of secondary IV sets is driven by the increasing number of chemotherapy infusions taking place in hospitals. IV extension sets, used to add length to access IV ports are seeing the highest increases in their use in neonatal intensive care units (NICUs).
Other key findings from the 2015 iData Research report series entitled Europe Markets for Infusion Therapy Devices:
DEHP Recommendations
Regulating agencies have issued warnings about the potential dangers of constructing IV sets and their accessories out of plastics containing di-2-ethylhexyl phthalate (DEHP). Because of these concerns, the European Commission recommends that manufacturers label their devices as containing DEHP, or consider replacing these devices with non-DEHP alternatives. Newer, non-DEHP tubing sets are sold at a higher price than their conventional counterparts, which is driving the IV set market.
Leading Competitors
B. Braun is the leading competitor in the European IV set market with over 30% market share. They have a strong presence in the large volume infusion pump markets in Europe, and because the IV sets used with large volume pumps are dedicated, the company derives a great part of its IV set unit sales from the installed base of these pumps.
Other notable competitors in intravenous set market include CareFusion, Fresenius Kabi, Codan, Hospira, Baxter International, Becton Dickinson, Doran International, ICU Medical, Smiths Medical, and Vygon among others.
For Further Information
More on the intravenous set market in Europe can be found in the report published by iData entitled Europe Markets for Infusion Therapy Devices. This report also covers European market segments for infusion pumps, intravenous sets, and needleless connectors.
The iData series on the market for infusion therapy devices covers the U.S., Japan, South Korea, Australia, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment.
To find out more about European intravenous set market data or procedure data, register online or email us at info@idataresearch.net for a Europe Markets for Infusion Therapy Devices report brochure and synopsis.
About Procedure Tracker
Additional procedure number data is available from iData's Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology, and more.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/06/prweb12766788.htm